Myriad Genetics (MYGN) Net Income towards Common Stockholders Growth (3y) (2012 - 2026)
Myriad Genetics (MYGN) Net Income towards Common Stockholders Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | -35.92% |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | 8.73% |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | -10.37% |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | 9.16% |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | 3.93% |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | -21.46% |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | 14.66% |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | 254.81% |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | -3.48% |
| 10 | Myriad Genetics | 414.15 Mn | 289.75 Mn | 137.60 Mn | 14.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.57% |
| Dec 31, 2025 | 42.84% |
| Sep 30, 2025 | 7.92% |
| Jun 30, 2025 | -186.19% |
| Mar 31, 2025 | 83.04% |
| Dec 31, 2024 | -77.50% |
| Sep 30, 2024 | -42.58% |
| Jun 30, 2024 | -98.39% |
| Mar 31, 2024 | 13.01% |
| Dec 31, 2023 | 16.24% |
| Sep 30, 2023 | -59.17% |
| Jun 30, 2023 | -27.89% |
| Mar 31, 2023 | 21.98% |
| Dec 31, 2022 | -72.09% |
| Sep 30, 2022 | -19.44% |
| Jun 30, 2022 | -48.57% |
| Mar 31, 2022 | -70.67% |
| Dec 31, 2021 | -70.12% |
| Sep 30, 2021 | 219.94% |
| Jun 30, 2021 | -32.46% |